Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,900 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 January 2022) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 6MB, 247 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

 

 

Export 2949 results:
Author Title Type [ Year(Asc)]
2021
P. Padmanathan, Forbes, H., Redaniel, M. T., Gunnell, D., Lewer, D., Moran, P., Watson, B., Degenhardt, L., and Hickman, M., Self-harm and suicide during and after opioid agonist treatment among primary care patients in England: a cohort study, Lancet Psychiatry, 2021.
J. Fortuny, Plana, E., and Kaye, J. A., Serum lipid trajectories in the years before a lymphoma diagnosis, Leuk Lymphoma, pp. 1-13, 2021.
R. K. Akyea, Vinogradova, Y., Qureshi, N., Patel, R. S., Kontopantelis, E., Ntaios, G., Asselbergs, F. W., Kai, J., and Weng, S. F., Sex, Age, and Socioeconomic Differences in Nonfatal Stroke Incidence and Subsequent Major Adverse Outcomes, Stroke, vol. 52, pp. 396-405, 2021.
R. K. Akyea, Kontopantelis, E., Kai, J., Weng, S. F., Patel, R. S., Asselbergs, F. W., and Qureshi, N., Sex disparity in subsequent outcomes in survivors of coronary heart disease, Heart, 2021.
V. C. Brunetti, Reynier, P., Azoulay, L., Yu, O. H. Y., Ernst, P., Platt, R. W., and Filion, K. B., SGLT-2 inhibitors and the risk of hospitalization for community-acquired pneumonia: A population-based cohort study, Pharmacoepidemiol Drug Saf, 2021.
V. Palin, Welfare, W., Ashcroft, D. M., and van Staa, T. P., Shorter and longer courses of antibiotics for common infections and the association with reductions of infection-related complications including hospital admissions, Clin Infect Dis, 2021.
A. J. McKay, Gunn, L. H., Ference, B. A., Dorresteijn, J. A. N., Berkelmans, G. F. N., Visseren, F. L. J., and Ray, K. K., Is the SMART risk prediction model ready for real-world implementation? A validation study in a routine care setting of approximately 380 000 individuals, Eur J Prev Cardiol, 2021.
C. H. Coughlan, Ruzangi, J., Neale, F. K., B. Maldonado, N., Blair, M., Bottle, A., Saxena, S., and Hargreaves, D., Social and ethnic group differences in healthcare use by children aged 0-14 years: a population-based cohort study in England from 2007 to 2017, Arch Dis Child, 2021.
J. L. Walker, Rentsch, C. T., McDonald, H. I., Bak, J., Minassian, C., Amirthalingam, G., Edelstein, M., and Thomas, S., Social determinants of pertussis and influenza vaccine uptake in pregnancy: a national cohort study in England using electronic health records, BMJ Open, vol. 11, p. e046545, 2021.
M. C. Smith, Ashdown, H. F., Sheppard, J. P., Butler, C. C., and Bankhead, C., Statin prescription in patients with chronic obstructive pulmonary disease and risk of exacerbations: a retrospective cohort study in the Clinical Practice Research Datalink, BMJ Open, vol. 11, p. e050757, 2021.
B. Iyen, Akyea, R. K., Weng, S., Kai, J., and Qureshi, N., Statin treatment and LDL-cholesterol treatment goal attainment among individuals with familial hypercholesterolaemia in primary care, Open Heart, vol. 8, 2021.
G. J. Lefeber, Knol, W., Souverein, P. C., Bouvy, M. L., de Boer, A., and Koek, H. L., Statins After Ischemic Stroke in the Oldest: A Cohort Study Using the Clinical Practice Research Datalink Database, Stroke, p. Strokeaha120030755, 2021.
K. Phiri, Hallas, J., Linder, M., Margulis, A., Suehs, B., Arana, A., Bahmanyar, S., Hoffman, V., Enger, C., Horter, L., Odsbu, I., Olesen, M., Perez-Gutthann, S., Kristiansen, N. S., Appenteng, K., de Vogel, S., and Seeger, J., A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder, Curr Med Res Opin, p. 1, 2021.
S. Swain, Coupland, C., Mallen, C., Kuo, C. F., Sarmanova, A., Bierma-Zeinstra, S. M. A., Englund, M., Prieto-Alhambra, D., Doherty, M., and Zhang, W., Temporal relationship between osteoarthritis and comorbidities: a combined case control and cohort study in the UK primary care setting, Rheumatology (Oxford), 2021.
L. Cybulski, Ashcroft, D. M., Carr, M. J., Garg, S., Chew-Graham, C. A., Kapur, N., and Webb, R. T., Temporal trends in annual incidence rates for psychiatric disorders and self-harm among children and adolescents in the UK, 2003-2018, BMC Psychiatry, vol. 21, p. 229, 2021.
J. van Dalem, Driessen, J. H. M., Burden, A. M., Stehouwer, C. D. A., Klungel, O. H., de Vries, F., and Brouwers, M., Thiazolidinediones and Glucagon-like Peptide-1 Receptor Agonists and the Risk of Nonalcoholic Fatty Liver Disease: A Cohort Study, Hepatology, 2021.
G. Russell, Stapley, S., Newlove-Delgado, T., Salmon, A., White, R., Warren, F., Pearson, A., and Ford, T., Time trends in autism diagnosis over 20 years: a UK population-based cohort study, J Child Psychol Psychiatry, 2021.
L. B. Ou, Azoulay, L., Reynier, P., Platt, R. W., Yoon, S., Grad, R., and Filion, K. B., Tramadol versus Codeine and the Short-term Risk of Cardiovascular Events in Patients with Non-Cancer Pain: A Population-Based Cohort Study, Br J Clin Pharmacol, 2021.
V. Papez, Moinat, M., Payralbe, S., Asselbergs, F. W., Lumbers, R. T., Hemingway, H., Dobson, R., and Denaxas, S., Transforming and evaluating electronic health record disease phenotyping algorithms using the OMOP common data model: a case study in heart failure, JAMIA Open, vol. 4, p. ooab001, 2021.
J. Pearson-Stuttard, Cheng, Y. J., Bennett, J., Vamos, E. P., Zhou, B., Valabhji, J., Cross, A. J., Ezzati, M., and Gregg, E. W., Trends in leading causes of hospitalisation of adults with diabetes in England from 2003 to 2018: an epidemiological analysis of linked primary care records, Lancet Diabetes Endocrinol, 2021.
A. Rahman, Kane, J., Montastruc, F., and Renoux, C., Trends in new prescription of gabapentinoids and of coprescription with opioids in the 4 nations of the UK, 1993-2017, Br J Clin Pharmacol, 2021.
J. Pearson-Stuttard, Bennett, J., Cheng, Y. J., Vamos, E. P., Cross, A. J., Ezzati, M., and Gregg, E. W., Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: an epidemiological analysis of linked primary care records, Lancet Diabetes Endocrinol, vol. 9, pp. 165-173, 2021.
L. Szatkowski, Vaz, L. R., Fiaschi, L., Tata, L., and Coleman, T., Trends in prescribing of nicotine replacement therapy to pregnant women in primary care in England, Nicotine Tob Res, 2021.
E. F. Pujol, Hancock, R., and Morciano, M., Trends in survival of older care home residents in England: A 10-year multi-cohort study, Soc Sci Med, p. 113883, 2021.
C. Archer, Turner, K., Kessler, D., Mars, B., and Wiles, N., Trends in the recording of anxiety in UK primary care: a multi-method approach, Soc Psychiatry Psychiatr Epidemiol, pp. 1-12, 2021.
S. Suissa, Dell'Aniello, S., and Ernst, P., Triple Inhaler versus Dual Bronchodilator Therapy in COPD: Real-World Effectiveness on Mortality, Copd, pp. 1-9, 2021.
J. L. Walker, Grint, D. J., Strongman, H., Eggo, R. M., Peppa, M., Minassian, C., Mansfield, K. E., Rentsch, C. T., Douglas, I. J., Mathur, R., Wong, A. Y. S., Quint, J. K., Andrews, N., Bernal, J. L., Scott, J. A., Ramsay, M., Smeeth, L., and McDonald, H. I., UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health records, BMC Public Health, vol. 21, p. 484, 2021.
Y. H. Yu, Filion, K. B., Reynier, P., Platt, R. W., Yu, O. H. Y., and Grandi, S. M., Use of levothyroxine among pregnant women with subclinical hypothyroidism in the United Kingdom: A population-based assessment, Pharmacol Res Perspect, vol. 9, p. e00848, 2021.
Y. Vinogradova, Dening, T., Hippisley-Cox, J., Taylor, L., Moore, M., and Coupland, C., Use of menopausal hormone therapy and risk of dementia: nested case-control studies using QResearch and CPRD databases, Bmj, vol. 374, p. n2182, 2021.
M. Ali, Landeira, M., Covernton, P. J. O., Choudhury, N., Jaggi, A., Fatoye, F., and van Maanen, R., The use of mono- and combination drug therapy in men and women with lower urinary tract symptoms (LUTS) in the UK: a retrospective observational study, BMC Urol, vol. 21, p. 119, 2021.
N. F. Khan, Booth, H. P., Myles, P., Mullett, D., Gallagher, A., Evans, C., Thomas, N., and Valentine, J., Use of prescribing safety quality improvement reports in UK general practices: a qualitative assessment, BMC Health Serv Res, vol. 21, p. 394, 2021.
A. Green, Tillett, W., McHugh, N., and Smith, T., Using Bayesian Networks to identify musculoskeletal symptoms influencing the risk of developing Psoriatic Arthritis in people with psoriasis, Rheumatology (Oxford), 2021.
M. S. M. Persson, Harman, K. E., Thomas, K. S., Chalmers, J. R., Vinogradova, Y., Langan, S. M., Hippisley-Cox, J., and Gran, S., Using electronic health records to inform trial feasibility in a rare autoimmune blistering skin disease in England, BMC Med Res Methodol, vol. 21, p. 22, 2021.
D. Roy, Akriche, F., Amlani, B., and Shakir, S., Utilisation and Safety of Polyethylene Glycol 3350 with Electrolytes in Children Under 2 Years: A Retrospective Cohort, J Pediatr Gastroenterol Nutr, 2021.
A. Douros, Cui, Y., Platt, R. W., Filion, K. B., Sebastiani, G., and Renoux, C., Utilization and long-term persistence of direct oral anticoagulants among patients with non-valvular atrial fibrillation and liver disease, Br J Clin Pharmacol, 2021.
G. Requena, Dedman, D., Quint, J. K., Ghosh, R. E., Williams, R., and Pimenta, J. M., The Utilization and Safety of Umeclidinium and Umeclidinium/Vilanterol in UK Primary Care: A Retrospective Cohort Study, Int J Chron Obstruct Pulmon Dis, vol. 16, pp. 629-642, 2021.
L. M. Lix, Sobhan, S., St-Jean, A., Daigle, J. M., Fisher, A., Yu, O. H. Y., Dell'Aniello, S., Hu, N., Bugden, S. C., Shah, B. R., Ronksley, P. E., Alessi-Severini, S., Douros, A., Ernst, P., and Filion, K. B., Validity of an algorithm to identify cardiovascular deaths from administrative health records: a multi-database population-based cohort study, BMC Health Serv Res, vol. 21, p. 758, 2021.
T. Burkard, Rauch, M., Jick, S. S., and Meier, C. R., Validity of bariatric surgery codes in the UK Clinical Practice Research Datalink (CPRD) GOLD compared with Hospital Episodes Statistics, Pharmacoepidemiol Drug Saf, 2021.
J. A. Prior, Crawford-Manning, F., Whittle, R., Abdul-Sultan, A., Chew-Graham, C. A., Muller, S., Shepherd, T. A., Sumathipala, A., Mallen, C. D., and Paskins, Z., Vertebral fracture as a risk factor for self-harm: a retrospective cohort study, BMC Musculoskelet Disord, vol. 22, p. 757, 2021.
C. Lee, Waite, F., Smith, M. C., Gao, M., Bankhead, C., Aveyard, P., and Piernas, C., Weight change, cardio-metabolic risk factors and cardiovascular incidence in people with serious mental illness: protocol of a population-based cohort study in the UK from 1998 to 2020, BMJ Open, vol. 11, p. e053427, 2021.
B. Torlinska, Hazlehurst, J. M., Nirantharakumar, K., Thomas, G. N., Priestley, J. R., Finnikin, S. J., Saunders, P., Abrams, K. R., and Boelaert, K., wEight chanGes, caRdio-mEtabolic risks and morTality in patients with hyperthyroidism (EGRET): a protocol for a CPRD-HES linked cohort study, BMJ Open, vol. 11, p. e055219, 2021.
C. L. Haase, Lopes, S., Olsen, A. H., Satylganova, A., Schnecke, V., and McEwan, P., Weight loss and risk reduction of obesity-related outcomes in 0.5 million people: evidence from a UK primary care database, Int J Obes (Lond), 2021.
G. Nakafero, Grainge, M. J., Card, T., Mallen, C. D., Zhang, W., Doherty, M., Taal, M. W., Aithal, G. P., and Abhishek, A., What is the incidence of methotrexate or leflunomide discontinuation related to cytopenia, liver enzyme elevation or kidney function decline?, Rheumatology (Oxford), 2021.
T. R. Berni, Morgan, C. L., and Rees, D. A., Women with Polycystic Ovary Syndrome have an increased risk of major cardiovascular events: a population study, J Clin Endocrinol Metab, 2021.
J. Erwin, Enki, D. G., and Woolf, A. D., Younger people with rheumatoid arthritis are at increased risk of fracture even before age 50 years: a population-based cohort study, Osteoporos Int, 2021.
G. Nakafero, Grainge, M. J., Valdes, A. M., Townsend, N., Mallen, C., Zhang, W., Doherty, M., Mamas, M., and Abhishek, A., β-blocker prescription is associated with lower cumulative risk of knee osteoarthritis and knee pain consultations in primary care: a propensity score matched cohort study, Rheumatology (Oxford), 2021.
[Page last reviewed 4 January 2022]